Glaucoma eye drop adherence with easygrip bottle
This study looks at how well people stick to their glaucoma eye drop routine when using a special bottle called EASYGRIP®. If you use this type of bottle for your glaucoma drops, this study may help doctors understand how to make treatment easier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have open-angle glaucoma or high pressure in the eye (ocular hypertension) in both eyes.
- You must be using a specific glaucoma eye drop (in an EASYGRIP® bottle) for at least 6 weeks, and it should be your only eye drop for glaucoma.
- You must be willing to participate and allow your data to be collected.
- You cannot be pregnant or breastfeeding.
- You cannot be using other eye drops for a chronic condition (like long-term dry eye treatment).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether reminders and extra check-ins help people with glaucoma stay on track with their eye drops and clinic visits. It aims to see if these supports keep eyes healthier by preventing missed drops and appointments.
This study tests a smart cap for your eye drop bottle that records when you use your drops. It is for people with glaucoma who sometimes miss doses and want to track their adherence with a phone app.
This study checks whether a device called the Nanodropper helps deliver glaucoma medicine as well as standard use. It is for adults with stable primary open-angle glaucoma (or ocular hypertension) who are on a limited number of eye-pressure medicines.
This study tests an eye drop (G01) for people with primary open-angle glaucoma that is getting worse despite current treatments. It aims to see if G01 can safely slow down or stop the progression of glaucoma.
This study looks at tools to help people use their glaucoma eyedrops correctly. You may be eligible if you've been on the same drops for 2 months and are a patient at Boston University Eye Associates.
This trial tests an investigational eye drop called ASP2767 to see if it is safe and can help slow or prevent further vision loss in people with advanced glaucoma-related optic nerve damage.
Hear when a new Adherence to Glaucoma Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.